{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:02Z","timestamp":1790985242800,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute myeloid leukaemia (AML) remains a therapeutically challenging malignancy owing to its high relapse rates and chemoresistance, often linked to elevated antioxidant defences. Here, we demonstrate that bone marrow stromal cells (BMSCs) confer chemoresistance in AML by upregulating the purinergic receptor P2RX7. Blocking P2RX7 restored chemosensitivity of AML cells. Mechanistically, BMSC-mediated P2RX7 overexpression induces calcium influx and mitochondrial calcium overload, triggering mitochondrial stress and a compensatory antioxidant response. This process involves mitochondrial phosphoglycerate mutase 5 (PGAM5) transducing reactive oxygen species signals, interfering with Keap1\u2013Nrf2 complex formation and leading to Nrf2 stabilization, thereby enhancing cellular antioxidant defences. These findings identify a vital role of P2RX7 in the BMSC-driven redox adaptation programme that underlies AML chemoresistance and highlight P2RX7 signalling as a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s12276-026-01839-4","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:22:56Z","timestamp":1788430976000},"page":"3025-3041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow stromal cells promote chemoresistance in acute myeloid leukaemia through P2RX7-mediated antioxidant defence"],"prefix":"10.1038","volume":"58","author":[{"given":"Ruolan","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4858-5337","authenticated-orcid":false,"given":"Cen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoqing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"1839_CR1","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-020-0710-x","volume":"21","author":"PK Reville","year":"2020","unstructured":"Reville, P. K. & Kadia, T. Individualizing treatment for newly diagnosed acute myeloid leukemia. Curr. Treat. Options Oncol. 21, 34 (2020).","journal-title":"Curr. Treat. Options Oncol."},{"key":"1839_CR2","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell, L. F. & Cook, R. J. Advances in acute myeloid leukemia. BMJ 375, N2026 (2021).","journal-title":"BMJ"},{"key":"1839_CR3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ijc.33908","volume":"150","author":"S Ganesan","year":"2022","unstructured":"Ganesan, S., Mathews, V. & Vyas, N. Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough? Int. J. Cancer 150, 1401\u20131411 (2022).","journal-title":"Int. J. Cancer"},{"key":"1839_CR4","volume":"532","author":"R You","year":"2022","unstructured":"You, R. et al. Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells. Cancer Lett. 532, 215582 (2022).","journal-title":"Cancer Lett."},{"key":"1839_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","volume":"128","author":"R Moschoi","year":"2016","unstructured":"Moschoi, R. et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood 128, 253\u2013264 (2016).","journal-title":"Blood"},{"key":"1839_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccr.2011.09.011","volume":"20","author":"L Li","year":"2011","unstructured":"Li, L. et al. Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia\/acute myeloid leukemia and identifies patients at risk. Cancer Cell 20, 591\u2013605 (2011).","journal-title":"Cancer Cell"},{"key":"1839_CR7","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.cmet.2023.10.011","volume":"35","author":"YW Cheng","year":"2023","unstructured":"Cheng, Y. W., Liu, J. & Finkel, T. Mitohormesis. Cell Metab. 35, 1872\u20131886 (2023).","journal-title":"Cell Metab."},{"key":"1839_CR8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cmet.2020.10.002","volume":"33","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Upregulation of antioxidant capacity and nucleotide precursor availability suffices for oncogenic transformation. Cell Metab. 33, 94\u2013109.e8 (2021).","journal-title":"Cell Metab."},{"key":"1839_CR9","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood.2021011510","volume":"139","author":"H Cai","year":"2022","unstructured":"Cai, H. et al. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression. Blood 139, 3040\u20133057 (2022).","journal-title":"Blood"},{"key":"1839_CR10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","volume":"32","author":"D Forte","year":"2020","unstructured":"Forte, D. et al. Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metab. 32, 829\u2013843.e9 (2020).","journal-title":"Cell Metab."},{"key":"1839_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/JLB.6A0821-409RR","volume":"112","author":"R You","year":"2022","unstructured":"You, R. et al. Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapy. J. Leukoc. Biol. 112, 299\u2013311 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"1839_CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3389\/fphar.2020.00793","volume":"11","author":"R Lara","year":"2020","unstructured":"Lara, R. et al. P2X7 in cancer: from molecular mechanisms to therapeutics. Front. Pharmacol. 11, 793\u2013822 (2020).","journal-title":"Front. Pharmacol."},{"key":"1839_CR13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2019.243360","volume":"106","author":"W Feng","year":"2021","unstructured":"Feng, W. et al. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3. Haematologica 106, 1278\u20131289 (2021).","journal-title":"Haematologica"},{"key":"1839_CR14","volume":"131","author":"X He","year":"2021","unstructured":"He, X. et al. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models. J. Clin. Invest. 131, e140242 (2021).","journal-title":"J. Clin. Invest."},{"key":"1839_CR15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/cells9040995","volume":"9","author":"H Park","year":"2020","unstructured":"Park, H. & Kim, J. E. Deletion of P2X7 receptor decreases basal glutathione level by changing glutamate-glutamine cycle and neutral amino acid transporters. Cells 9, 995\u20131007 (2020).","journal-title":"Cells"},{"key":"1839_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L. & Falzoni, S. The P2X7 receptor in infection and inflammation. Immunity 47, 15\u201331 (2017).","journal-title":"Immunity"},{"key":"1839_CR17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto, M., Kensler, T. W. & Motohashi, H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol. Rev. 98, 1169\u20131203 (2018).","journal-title":"Physiol. Rev."},{"key":"1839_CR18","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12503","volume":"65","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. Inhibitory effect of melatonin on necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway attenuates cardiac microvascular ischemia-reperfusion injury. J. Pineal. Res. 65, e12503 (2018).","journal-title":"J. Pineal. Res."},{"key":"1839_CR19","volume":"42","author":"S Nag","year":"2023","unstructured":"Nag, S. et al. PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics. Cell Rep. 42, 112895 (2023).","journal-title":"Cell Rep."},{"key":"1839_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16312-7","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu, B. et al. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat. Commun. 11, 2549 (2020).","journal-title":"Nat. Commun."},{"key":"1839_CR21","volume":"48","author":"A Zeb","year":"2021","unstructured":"Zeb, A. et al. A novel role of KEAP1\/PGAM5 complex: ROS sensor for inducing mitophagy. Redox Biol. 48, 102186 (2021).","journal-title":"Redox Biol."},{"key":"1839_CR22","volume":"10","author":"W Shao","year":"2024","unstructured":"Shao, W. et al. LFHP-1c improves cognitive function after TBI in mice by reducing oxidative stress through the PGAM5-NRF2-KEAP1 ternary complex. Heliyon 10, e36820 (2024).","journal-title":"Heliyon"},{"key":"1839_CR23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/2211-5463.13165","volume":"11","author":"ZP Pan","year":"2021","unstructured":"Pan, Z. P. et al. METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia. FEBS Open Biol. 11, 1659\u20131672 (2021).","journal-title":"FEBS Open Biol."},{"key":"1839_CR24","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1182\/bloodadvances.2024015496","volume":"9","author":"D Hou","year":"2025","unstructured":"Hou, D. et al. Targeting bone marrow mesenchymal stromal cells-derived IL-6 to overcome acute myeloid leukemia chemoresistance. Blood Adv. 9, 4810\u20134824 (2025).","journal-title":"Blood Adv."},{"key":"1839_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06325-7","volume":"14","author":"X Liao","year":"2023","unstructured":"Liao, X. et al. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy. Cell Death Dis. 14, 796 (2023).","journal-title":"Cell Death Dis."},{"key":"1839_CR26","volume":"187","author":"F Di Virgilio","year":"2021","unstructured":"Di Virgilio, F., Vultaggio-Poma, V. & Sarti, A. C. P2X receptors in cancer growth and progression. Biochem. Pharmacol. 187, 114350 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"1839_CR27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tips.2006.02.004","volume":"27","author":"N White","year":"2006","unstructured":"White, N. & Burnstock, G. P2 receptors and cancer. Trends Pharmacol. Sci. 27, 211\u2013217 (2006).","journal-title":"Trends Pharmacol. Sci."},{"key":"1839_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02660-5","volume":"22","author":"A Khodakarami","year":"2022","unstructured":"Khodakarami, A. et al. The molecular biology and therapeutic potential of Nrf2 in leukemia. Cancer Cell Int. 22, 241 (2022).","journal-title":"Cancer Cell Int."},{"key":"1839_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega, M., Chapman, E. & Zhang, D. D. NRF2 and the hallmarks of cancer. Cancer Cell 34, 21\u201343 (2018).","journal-title":"Cancer Cell"},{"key":"1839_CR30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102726","volume":"63","author":"S Adinolfi","year":"2023","unstructured":"Adinolfi, S. et al. The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol. 63, 102726 (2023).","journal-title":"Redox Biol."},{"key":"1839_CR31","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/leu.2009.175","volume":"23","author":"F Ayala","year":"2009","unstructured":"Ayala, F., Dewar, R., Kieran, M. & Kalluri, R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23, 2233\u20132241 (2009).","journal-title":"Leukemia"},{"key":"1839_CR32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 98, 502\u2013526 (2023).","journal-title":"Am. J. Hematol."},{"key":"1839_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ncb2432","volume":"14","author":"W Zhang","year":"2012","unstructured":"Zhang, W. et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat. Cell Biol. 14, 276\u2013286 (2012).","journal-title":"Nat. Cell Biol."},{"key":"1839_CR34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117148","volume":"241","author":"H Rizwan","year":"2020","unstructured":"Rizwan, H., Pal, S., Sabnam, S. & Pal, A. High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes. Life Sci. 241, 117148 (2020).","journal-title":"Life Sci."},{"key":"1839_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung, E. C. & Vousden, K. H. The role of ROS in tumour development and progression. Nat. Rev. Cancer 22, 280\u2013297 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1839_CR36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2014.01.011","volume":"19","author":"J Yun","year":"2014","unstructured":"Yun, J. & Finkel, T. Mitohormesis. Cell Metab. 19, 757\u2013766 (2014).","journal-title":"Cell Metab."},{"key":"1839_CR37","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","volume":"14","author":"AI Sheth","year":"2024","unstructured":"Sheth, A. I. et al. Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium. Cancer Discov. 14, 1922\u20131939 (2024).","journal-title":"Cancer Discov."},{"key":"1839_CR38","volume":"8","author":"J Kanellopoulos","year":"2013","unstructured":"Kanellopoulos, J. et al. P2X7 integrates PI3K\/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS ONE 8, e60184 (2013).","journal-title":"PLoS ONE"},{"key":"1839_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-017-9593-0","volume":"14","author":"G Burnstock","year":"2017","unstructured":"Burnstock, G. & Knight, G. E. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. Purinergic Signal. 14, 1\u201318 (2017).","journal-title":"Purinergic Signal."},{"key":"1839_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00635-6","volume":"14","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK\/STAT pathway. Exp. Hematol. Oncol. 14, 43 (2025).","journal-title":"Exp. Hematol. Oncol."},{"key":"1839_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-021-00220-7","volume":"10","author":"T Lyu","year":"2021","unstructured":"Lyu, T. et al. Exosomes from BM-MSCs promote acute myeloid leukemia cell proliferation, invasion and chemoresistance via upregulation of S100A4. Exp. Hematol. Oncol. 10, 24 (2021).","journal-title":"Exp. Hematol. Oncol."},{"key":"1839_CR42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3724\/abbs.2024230","volume":"57","author":"W Zhang","year":"2025","unstructured":"Zhang, W., Tian, W., Xia, X., Tian, H. & Sun, T. AKR1C3 protects cardiomyocytes against hypoxia-induced cell apoptosis through the Nrf-2\/NF-\u03baB pathway. Acta Biochim. Biophys. Sin. 57, 1151\u20131163 (2025).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"1839_CR43","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.7150\/ijbs.98846","volume":"20","author":"J Shrestha","year":"2024","unstructured":"Shrestha, J. et al. Antioxidant genes in cancer and metabolic diseases: focusing on Nrf2, sestrin, and heme oxygenase 1. Int. J. Biol. Sci. 20, 4888\u20134907 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"1839_CR44","volume":"21","author":"L Zhu","year":"2022","unstructured":"Zhu, L. et al. Chaperone-mediated autophagy degrades Keap1 and promotes Nrf2-mediated antioxidative response. Aging Cell 21, e13616 (2022).","journal-title":"Aging Cell"},{"key":"1839_CR45","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.chembiol.2023.07.014","volume":"30","author":"L Ibrahim","year":"2023","unstructured":"Ibrahim, L. et al. Succinylation of a KEAP1 sensor lysine promotes NRF2 activation. Cell Chem. Biol. 30, 1295\u20131302.e4 (2023).","journal-title":"Cell Chem. Biol."},{"key":"1839_CR46","volume":"120","author":"Y Ko","year":"2023","unstructured":"Ko, Y. et al. S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. Proc. Natl Acad. Sci. USA 120, e2300763120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1839_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biochi.2018.12.008","volume":"158","author":"SS Wei","year":"2019","unstructured":"Wei, S. S. et al. Role of human Keap1 S53 and S293 residues in modulating the binding of Keap1 to Nrf2. Biochimie 158, 73\u201381 (2019).","journal-title":"Biochimie"},{"key":"1839_CR48","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1074\/jbc.M206911200","volume":"277","author":"HC Huang","year":"2002","unstructured":"Huang, H. C., Nguyen, T. & Pickett, C. B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769\u201342774 (2002).","journal-title":"J. Biol. Chem."},{"key":"1839_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2021.03.034","volume":"168","author":"T Liu","year":"2021","unstructured":"Liu, T., Lv, Y. F., Zhao, J. L., You, Q. D. & Jiang, Z. Y. Regulation of Nrf2 by phosphorylation: consequences for biological function and therapeutic implications. Free Radic. Biol. Med. 168, 129\u2013141 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"1839_CR50","volume":"180","author":"M Yan","year":"2024","unstructured":"Yan, M. et al. IL-33-dependent NF-\u03baB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia. Cytokine 180, 156672 (2024).","journal-title":"Cytokine"},{"key":"1839_CR51","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Activation of RAS\/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct. Target. Ther. 7, 51 (2022).","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01839-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:13Z","timestamp":1790982193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01839-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1839"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01839-4","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study involving human specimens was approved by the Committee for the Ethical Review of Research, Fujian Medical University Union Hospital (2023KJCX044). All experiments involving animals were performed according to a protocol approved by the Animal Ethics Committee of Fujian Medical University (Protocol No. IACUC FJMU 2024-0279) and performed in accordance with institutional guidelines.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}